These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 8825705)

  • 1. Seroepidemiological study of Epstein-Barr virus infection in Bangladesh.
    Haque T; Iliadou P; Hossain A; Crawford DH
    J Med Virol; 1996 Jan; 48(1):17-21. PubMed ID: 8825705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A comparison of the detection of IgM antibodies against the viral capsid antigen (VCA) of EBV (Epstein-Barr virus) in various groups of patients, using indirect immunofluorescence, indirect ELISA and reverse ELISA. Study of the diagnostic efficacy of the anti-VCA EBV IgM ELISA-VIDITEST kit].
    Pumannová M; Rezbová M; Svecová M; Hrbácková H; Novotná M; Ochotná J; Roubalová K
    Klin Mikrobiol Infekc Lek; 2004 Aug; 10(4):186-90. PubMed ID: 15328576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic importance of heterophile antibodies and immunoglobulins IgA, IgE, IgM and low-avidity IgG against Epstein-Barr virus capsid antigen in children.
    Votava M; Bartosová D; Krchnáková A; Crhová K; Kubinová L
    Acta Virol; 1996 Apr; 40(2):99-101. PubMed ID: 8886119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of immunoblot-based assay for detecting Epstein-Barr virus viral capsid antibodies].
    Altuğlu I; Aksoy A; Zeytinoğlu A; Orman M
    Mikrobiyol Bul; 2010 Apr; 44(2):231-6. PubMed ID: 20549957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-EBNA-1 (carboxy-half) IgG antibodies as a seroepidemiological marker for Epstein-Barr virus infection.
    Nebel-Schickel H; Hinderer W; Saavedra C; Schmutzler R; Horn J; Vornhagen R; Sonneborn HH
    Beitr Infusionsther Transfusionsmed; 1994; 32():134-7. PubMed ID: 9422107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a multiplex fluorescent microsphere immunoassay for the determination of epstein-barr virus serologic status.
    Martins TB; Litwin CM; Hill HR
    Am J Clin Pathol; 2008 Jan; 129(1):34-41. PubMed ID: 18089487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of multiple antibodies to Epstein-Barr virus as markers for detecting patients with nasopharyngeal carcinoma.
    Liu MY; Chang YL; Ma J; Yang HL; Hsu MM; Chen CJ; Chen JY; Yang CS
    J Med Virol; 1997 Jul; 52(3):262-9. PubMed ID: 9210034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of anti-Epstein-Barr virus antibodies in nasopharyngeal carcinoma (NPC).
    Liu MT; Yeh CY
    Radiat Med; 1998; 16(2):113-7. PubMed ID: 9650898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High incidence of elevated antibody titers to Epstein-Barr virus in patients with uveitis.
    Touge C; Agawa H; Sairenji T; Inoue Y
    Arch Virol; 2006 May; 151(5):895-903. PubMed ID: 16362642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of three different serological techniques for primary diagnosis and monitoring of nasopharyngeal carcinoma in two age groups from Tunisia.
    Karray H; Ayadi W; Fki L; Hammami A; Daoud J; Drira MM; Frikha M; Jlidi R; Middeldorp JM
    J Med Virol; 2005 Apr; 75(4):593-602. PubMed ID: 15714486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative study of the prevalence of Epstein-Barr virus infections in Iran and Germany].
    Alebouyeh M; Peller P; Goetz O; Ameri MA
    Monatsschr Kinderheilkd; 1984 Nov; 132(11):850-1. PubMed ID: 6096701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr virus-specific antibodies in Epstein-Barr virus-positive and -negative gastric carcinoma cases in Japan.
    Shinkura R; Yamamoto N; Koriyama C; Shinmura Y; Eizuru Y; Tokunaga M
    J Med Virol; 2000 Apr; 60(4):411-6. PubMed ID: 10686024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Epstein-Barr virus (EBV) antibody screening of organ donors for allocation of organs to EBV serostatus matched recipients.
    Lazda VA
    Transplant Proc; 2006 Dec; 38(10):3404-5. PubMed ID: 17175286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The serological signs of the Epstein-Barr virus (EBV) activity in the elderly.
    Ternák G; Szúcs G; Uj M
    Acta Microbiol Immunol Hung; 1997; 44(2):133-40. PubMed ID: 9330661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ELISA for the detection of serum and saliva IgA against the BMRFI gene product of Epstein-Barr virus.
    Nadala EC; Tan TM; Wong HM; Ting RC
    J Med Virol; 1996 Sep; 50(1):93-6. PubMed ID: 8890046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low prevalence of antibody to human herpesvirus-6 (HHV-6) in Kadazans.
    Yadav M; Umamaheswari S; Ablashi DV
    Southeast Asian J Trop Med Public Health; 1990 Jun; 21(2):259-63. PubMed ID: 2173152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Murine gammaherpesvirus 68 serum antibodies in general human population.
    Hricová M; Mistríková J
    Acta Virol; 2007; 51(4):283-7. PubMed ID: 18197737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sero-epidemiologic study of the Epstein--Barr virus infectivity in a healthy Cuban population.
    Gurtsevich V; Le Riverend E; Ruíz R
    Neoplasma; 1979; 26(6):677-83. PubMed ID: 232252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Epstein-Barr virus antibodies, anti-VCA avidity by immunofluorescence and immunoblot assays for assessment of Epstein-Barr virus immunologic state.
    Sener AG; Afsar I; Pinar E
    J Virol Methods; 2009 Aug; 159(2):300-2. PubMed ID: 19406156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High prevalence of immunoglobulin A antibody against Epstein-Barr virus capsid antigen in adult patients with lupus with disease flare: case control studies.
    Chen CJ; Lin KH; Lin SC; Tsai WC; Yen JH; Chang SJ; Lu SN; Liu HW
    J Rheumatol; 2005 Jan; 32(1):44-7. PubMed ID: 15630723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.